Publicaciones en colaboración con investigadores/as de Hospital Clinic Barcelona (27)

2009

  1. Control of hypertension in coronary heart disease

    International Journal of Cardiology, Vol. 134, Núm. 2, pp. 245-247

  2. Discrepancies between Office and Ambulatory Blood Pressure: Clinical Implications

    American Journal of Medicine, Vol. 122, Núm. 12, pp. 1136-1141

  3. Prevalence and factors associated with circadian blood pressure patterns in hypertensive patients

    Hypertension, Vol. 53, Núm. 3, pp. 466-472

2007

  1. Ambulatory blood pressure monitoring in hypertensive patients with high cardiovascular risk: A cross-sectional analysis of a 20 000-patient database in Spain

    Journal of Hypertension, Vol. 25, Núm. 5, pp. 977-984

  2. Amlodipine and valsartan: Calcium channel blockers/angiotensin II receptor blockers combination for hypertenion

    Therapy, Vol. 4, Núm. 1, pp. 31-40

  3. Are calcium channel blockers first-line drugs for the treatment of hypertension and cardiovascular disease?

    Current Hypertension Reviews, Vol. 3, Núm. 1, pp. 9-13

  4. Contribution of the CARDIORISC project to the management of hypertensive patients in Primary Health Care in Spain

    Semergen, Vol. 33, Núm. 9, pp. 495-501

  5. Effectiveness of blood pressure control outside the medical setting

    Hypertension, Vol. 49, Núm. 1, pp. 62-68

  6. Estratificación y grado de control del riesgo cardiovascular en la población hipertensa española. Resultados del estudio DICOPRESS

    Medicina Clinica, Vol. 129, Núm. 7, pp. 247-251

  7. Inhibidores de la renina. Una nueva forma de supresión farmacológica del sistema renina-angiotensina

    Medicina Clinica Monografias

  8. Monitorización ambulatoria de la presión arterial (MAPA): Características clínicas de 31.530 pacientes

    Medicina Clinica, Vol. 129, Núm. 1, pp. 1-5

  9. Response to influence of siesta in the estimation of blood pressure control in patients with hypertension [4]

    Hypertension

  10. Response to is siesta masking masked hypertension?

    Hypertension

  11. Response to out-of-office blood pressure control among treated subjects [6]

    Hypertension

  12. The kidney and cardiovascular risk - Implications for management: A consensus statement from the European Society of Hypertension

    Blood Pressure, Vol. 16, Núm. 2, pp. 72-79

2004

  1. Erectile dysfunction in essential arterial hypertension and effects of sildenafil: Results of a Spanish national study

    American Journal of Hypertension, Vol. 17, Núm. 2, pp. 139-145

  2. Novel antihypertensive agents

    Expert Opinion on Investigational Drugs, Vol. 13, Núm. 8, pp. 987-998